The untargeted chemometric methodology for the impurity profiling of amisulpride pharmaceutical formulations was successfully applied and developed. For this purpose a fast, accurate and specific analytical method was elaborated with the use of ultra high pressure liquid chromatography coupled with high resolution hybrid electrospray ionization quadrupole time of flight mass spectrometer in a fast polarity switching mode. All the obtained chromatographic profiles were aligned and a multivariate chemometric analysis including principal component analysis and partial least square (PLS) was performed. The developed PLS-DA pattern recognition model allowed the identification of all the analyzed pharmaceutical formulations of amisulpride as well as their manufacturers. Additionally, six impurities of amisulpride were identified by the use of MS/MS fragmentation and one of them was found as the main impurity (Imp-1) and can be regarded as the primary impurity "marker" for the analyzed formulations. Furthermore, one new impurity of amisulpride was found and its chemical structure was proposed (4-amino-5-(ethylsulfinyl)-2-methoxy-N-[(1-ethylpyrrolidin-2-yl)methyl]benzamide).
Introduction
The safety of the therapy is one of the most important factor during the pharmaceuticals application and it is determined by the pharmacological and toxicological profile of the used drug. What is important, the toxicological profile of the drug depends not only on the toxicity of the active substance but also on the impurities that may be present in the bulk substance as well as in dosage formulations. Therefore, nowadays the monitoring of the purity of drug substances and products is one of the most important part of the drug quality control (QC) process and is specified in pharmacopeias and ICH guidelines (1, 2) .
In the case of new substances and pharmaceutical products ICH guidelines are now generally used. The ICH Q3A guideline provides the definition of the impurity profile as a description of the identified and unidentified impurities present in a new drug substance. The Q3A guide also establishes the classification of the impurities into organic (process and drug related), inorganic and residual solvents. The ICH Q3B guideline concerns the impurities in new drug products as a result of a drug degradation process or reaction of a drug substance with excipients or immediate container/closure system. It should be noted that the degradation study of drugs is very important research from the viewpoint of the drug purity. The forced degradation procedures allow to obtain many new compounds formed from drugs under various stress conditions and it can be very helpful in the impurity profiling of pharmaceuticals (3, 4) .
Various analytical strategies and methods have been used so far for this kind of study; however, the targeted analysis and the separation techniques with the frequently used liquid chromatography were the most preferred (5-9). Nevertheless, today more and more often modern sophisticated hyphenated analytical tools like: LC-MS, LC-NMR, LC-FTIR etc. are used for the pharmaceutical impurities characterization. However, by the use of these advanced methods unambiguous results are sometimes obtained and an untargeted strategy does not give a satisfactory outcome (10, 11) . On the other hand, the chemeometric methodology with the use of principal component analysis (PCA) was efficiently used to the impurity profiling of the selected drugs basing on LC-Q-TOF (12) and LC-DAD (13) data. Thus, further studies are needed in this area in order to develop a fast, accurate and also more reliable analytical strategy.
Taking this into account, the aim of this study was to apply a untargeted chemometric strategy for the impurity profiling of amisulpride as an example of a valuable atypical antipsychotic drug (14-16) with so far not fully studied impurity/degradant profile (17) (18) (19) (20) .
For this purpose a hybrid high resolution LC-MS method to register specific impurity profiles of amisulpride ( Figure 1 ) was developed and based on the multivariate chemometric methods a partial least square discrimination model (PLS-DA) allowing the identification of available pharmaceutical formulations of this drug was built. In this study, the structural characterization of the main impurities presented in amisulpride bulk and dosage formulations was also performed.
Experimental

Materials
Amisulpride certified reference standard (CRS) was obtained from European Directorate for the Quality of Medicines & Healthcare (Council of Europe, Strasburg). All the pharmaceutical formulations of amisulpride available on the native market were obtained in a local pharmacy (Table I) . Methanol hypergrade for LC-MS was purchased from Merck (Darmstadt, Germany) and 98% formic acid for mass spectroscopy was obtained from Fluka (Taufkirchen, Germany). Water for ultra LC-MS was obtained from Fluka (St. Louis, USA).
Liquid chromatography-electrospray ionization quadrupole time of flight analysis LC-MS analysis was performed with the use of Agilent Accurate-Mass Q-TOF LC-MS G6520B system with dual electrospray ionization source and Infinity 1290 ultra high pressure liquid chromatography system consisting of: binary pomp G4220A, FC/ALS thermostat G1330B, autosampler G4226A, DAD detector G4212A, TCC G1316C module (Agilent Technologies, Santa Clara, USA) and Zorbax Eclipse-C18 (×2.150 mm, dp = 1.8 μm) HD column (Agilent Technologies, Santa Clara, USA). A mixture of methanol (A) and water (B) with addition of 0.1% solution of formic acid in both media was used as a mobile phase. The gradient elution was carried out at constant flow 0.3 mL/min from 5%A (95%B) 0-1 min and then 5%A to 80%A 1-9.5 min and next 80%A 9.5-10 min. Of the note, 2 min post time was performed to return to initial conditions. The injection volume was 2 µL and the column temperature was maintained at 25°C. MassHunter workstation software in version B.04.00 was used for the control of the system and data acquisition.
The optimization of the instrument conditions was set out from the proper tuning of Q-TOF detector in a positive and negative mode with the use of Agilent ESI-L tuning mix in the extended dynamic range (2 GHz). The following instrument settings were applied: gas temp.: 300°C, drying gas: 10 L/min, nebulizer pressure: 40 psig, capillary voltage: 3,500 V, fragmentor voltage: 150 V, skimmer voltage: 65 V, octopole 1 RF voltage: 250 V.
Data acquisition was performed in centroids with the use of the fast polarity switching (MS) mode. The spectral parameters were: mass range: 100-1050 m/z and the acquisition rate: 1.2 spectra/s. For MS/ MS experiments auto and targeted MS/MS modes were used and the spectral parameters were: mass range: 100-950 m/z and acquisition rate: 2 spectra/s. The collision energy (CID) was ranged: 25-40 eV.
To ensure accuracy in masses measurements, a reference mass correction was used. Masses 112.985587 and 1033.988109 (negative ionization) and 121.050873 and 922.009798 (positive ionization) were used as lock masses.
Sample preparation
For all the pharmaceutical formulations the average mass tablet was determined and the equivalents of 250 mg of amisulpride were transferred to 25 mL volumetric flasks containing 15 mL of methanol. After 5 min ultrasonic sweeping the samples were diluted up to volume with methanol, then centrifuged at 10,000 RPM/min for 5 min (at room temperature). All the supernatants were diluted 1:100 with methanol before LC-MS analysis.
The stock solution of CRS standard of amisulpride was prepared in methanol at concentration 0.5 mg/mL. Before the analysis CRS stock solution was diluted to the same concentration as the analyzed pharmaceutical formulation samples (0.1 mg/mL).
Method validation
In order to control the stability of LC-MS analysis the QC samples were prepared by pooling equal aliquots of all the analyzed formulations as well as of CRS standard. QC samples were analyzed before, during and after each batch run of the samples and the obtained results were used for the multivariate chemometric analysis. Additionally, for all QC samples nine ions (the potential impurities) were selected and the statistical differences of their retention time and peak intensity were examined in order to evaluate the repeatability of the method. 
Data analysis
The molecular feature extraction algorithm (MFE) from the MassHunter Qualitative Analysis software version B.06.00 (Agilent) was used for data background ion noise cleaning and to extract the list of the potential impurities. The MFE parameters were optimized and the following settings were applied: maximum 2 charge state of the analyzed ions, >5,000 counts for the compound filter, isotope model: common organic molecules with peak spacing tolerance 0.0025 m/z. In order to execute the multivariate chemometric analysis the obtained results were next exported to the Mass Profiler Professional (MPP) software version 12.6 (Agilent and Strand Life Sciences Pvt. Ltd.). With the use of this software the data were normalized and aligned and the PCA was performed in order to evaluate the quality of all the obtained results. Next the PLS-DA model was built using 2/3 of the obtained results (eight batches of the samples). The rest of the obtained data (three batches of the samples) was used to perform the cross-validation of the model.
Results
Optimization and validation of the LC-MS analysis
Based on our previous study the reversed-phase ultra high pressure liquid chromatography system and gradient elution with a mixture of methanol and water with addition of formic acid were used (20) .
The gradient elution was optimized and increased up to 80% of methanol in order to register all the potential impurities. As shown in Figure 2 , the registered profiles are very similar and the only slight difference was observed in the case of CRS standard of amisulpride. These results prompted us to use the advanced chemometrics tools in this study.
Spectral data acquisition was performed with the use of the fast polarity switching (FPS) mode which allows the registration of MS spectra in both polarizations at the same time without repeating the analysis. The use of the FPS mode also enabled building one combined chemometric model, rather than two separate models for each polarization.
The QC sample analysis was performed to evaluate the repeatability of the developed LC-MS method. The relative standard deviation of the retention times of the selected ions did not exceed 1.6% and in the case of peak intensity reached a maximum of 9% (Table II) which confirms the appropriate repeatability of the used analytical system.
Samples classification and prediction
In order to carry out the multivariate chemometric analysis all the obtained chromatographic profiles (110 chromatograms-11 batches of the samples including QC samples) were aligned with MPP software giving 204 entities. After a build-in MPP filtration including sample variability, abundance and Kruskal-Wallis statistical test, six entities were finally selected (ions presented in Table III ) for a chemometric study. The PCA based on this data showed a visible categorization of all 10 analyzed groups of samples ( Figure 3) . CRS samples visibly stood out from the dosage forms of amisulpride and could be considered as a control group. Concurrently, relatively small differences between the pharmaceutical formulations of the manufacturers A and B were also observed. The QC samples fitted exactly into the centre of the formulation samples which confirms the stability of the analytical system. In this PCA analysis the first three components (PC) explained 78.4% of the total variance. The PLS-DA pattern recognition model was built without QC samples based on the same six selected entities (Figure 4) . The overall accuracy of the obtained model was 87.5% and the crossvalidation procedure confirms the accuracy of the prediction at the level 81.5%. As shown in Figure 5 the ions labeled as Imp-1, Imp-3, Imp-4 and Imp-6 have the highest VIP scores and thus are the most Figure 3 . The 3D PCA plot of impurity profiles of eight pharmaceutical formulations of amisulpride (labeled according with Table I ), standard of amisulpride (CRS) and QC samples. Table I ). Table III) .
contributory variables in class discrimination in the evaluated chemometric model. The obtained results suggest that the developed PLS-DA model allows the identification of the manufacturer as well as the specific pharmaceutical formulation of amisulpride basing only on the impurity profiles of the analyzed samples.
Structural characterization of the main impurities
As shown in Table III their molecular ions were found with very good accuracy (1.62-3.59 ppm) and the corresponding chemical formulas were calculated. Four of these impurities (Imp-1, Imp-2, Imp-3 and Imp-4 - Figure 6 ) are described in the European Pharmacopoeia eighth as impurities B, D, H and C, respectively, and one (Imp-5) was described and characterized previously as a photodegradation product of amisupride (20) . One of these impurities (Imp-6) was found as a deoxidation product of amisulpride not yet described in literature. The proposed structure and fragmentation pathway of this impurity is presented in Figure 7 .
Discussion
The use of high resolution MS spectrometer enabled the registration of the accurate masses of the analyzed ions which is the basis for the identification of unknown compounds. The obtained results allow to calculate the chemical formulas of these compounds as well as can be used to search available databases of known substances (metabolites, drugs etc.). However, many of the compounds do not occur in available spectrometric databases, which especially concerns drug impurities, and it is necessary to perform additional MS/MS analysis. The Q-TOF analyzer can be easily switched from the FPS TOF (MS) mode to auto/targeted MS/MS mode and an accurate structural characterization can be performed. In this study by TOF (MS) and next MS/MS analyses six main impurities were identified and structurally characterized. It should be noted that impurity Imp-1 was found as the main impurity and taking into account their relative distribution in the analyzed samples ( Figure 8 ) this impurity can be regarded as the primary impurity "marker". However, the exact classification of all the analyzed forms of amisulpride is not possible without the use of the developed PLS-DA pattern recognition model and Imp-1 can be used for the preliminary identification and qualification of the amisulpride pharmaceutical formulations as well as a bulk substance.
Conclusion
A hybrid high resolution LC-MS method with FPS technique allowing the registration of specific impurity profiles of amisulpride has been developed. Based on the above method, the untargeted strategy was successfully applied to the impurity characterization of amisulpride pharmaceutical formulations. The built PLS-DA pattern recognition model allowed the identification of all the analyzed dosage forms of this drug as well as their manufacturers.
The main impurity found (Imp-1) was structurally characterized and can be regarded as the primary impurity "marker" for all the analyzed formulations and the bulk substance of amisulpride. Additionally, one new impurity of amisulpride (Imp-6) was found and its chemical structure based on the MS/MS fragmentation was proposed (4-amino-5-(ethylsulfinyl)-2-methoxy-N-[(1-ethylpyrrolidin-2-yl)methyl]benzamide). 
